APA (7th ed.) Citation

R, R., Y, X., X, C., M, Z., X, W., T, W., . . . S, L. (2026). Doxycycline treatment for drug-resistant Mycoplasma pneumoniae pneumonia and evaluation of key predictive factors for refractory disease. Frontiers in medicine, 13, 1714717. https://doi.org/10.3389/fmed.2026.1714717

Chicago Style (17th ed.) Citation

R, Ren, Xu Y, Cui X, Zhang M, Wu X, Wang T, Liu X, and Li S. "Doxycycline Treatment for Drug-resistant Mycoplasma Pneumoniae Pneumonia and Evaluation of Key Predictive Factors for Refractory Disease." Frontiers in Medicine 13 (2026): 1714717. https://doi.org/10.3389/fmed.2026.1714717.

MLA (9th ed.) Citation

R, Ren, et al. "Doxycycline Treatment for Drug-resistant Mycoplasma Pneumoniae Pneumonia and Evaluation of Key Predictive Factors for Refractory Disease." Frontiers in Medicine, vol. 13, 2026, p. 1714717, https://doi.org/10.3389/fmed.2026.1714717.